Contact Us Product Guide Drug Information Site Map
$40.04 +$0.07 (Up 0.4%) Volume: 904,022 May 09, 2008 Barr Announces Approval of Generic Yasmin(R)... May 08, 2008 Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share;... May 21, 2008 Barr Pharmaceuticals, Inc. at Citigroup Healthcare Conference May 28, 2008 Barr Pharmaceuticals, Inc. at Sanford C. Bernstein & Co. Strategic Decisions Conference
Barr Pharmaceuticals, Inc.			Terms of Use Legal Notice Privacy Policy

Mission Corporate Profile Business Strategies Annual Report Facilities Government Affairs Barr History

Generic Business Overview Generic Business Strategies Key Generic Products Generic Product Pipeline Generic Sales Process FAQ About Generics Generic Drug FDA Approval Process History of Generic Industry Industry Links Clinical Trials

Proprietary Business Overview Proprietary Business Strategies Key Marketed Proprietary Products Proprietary Product Pipeline Proprietary Sales Force FDA Approval Process Clinical Trials

Corporate Profile Stock Quote Financials Fact Sheets Annual Reports 2008 Proxy Online Current Investor Presentation Analyst Coverage Calendar of Events Audio Archives and Presentations SEC Filings Corporate Governance E-Mail Alerts Information Request

Career Opportunities Corporate Profile Mission Financials Generic Business Overview Key Generic Products Proprietary Business Overview Key Proprietary Products Proprietary Product Sales Forces